PediatricsConsultantLive Members: Login | Register

 
PHOTOCLINIC

Scarlet Fever Rash
July 28, 2011

Rarely encountered these days, scarlet fever is believed to be caused by sensitization to an erythrogenic toxin produced by strains of group A beta-hemolytic streptococci.

Cephalhematoma
July 22, 2011

A right parietal cephalhematoma was first noted on this 2-week-old girl 2 days after her birth.

Scarlet Fever
June 21, 2011

A 2-day history of fever and sore throat and an erupting rash prompted the mother of a 5-year-old boy to bring her son into the office for evaluation.


 
CLINICAL TRIALS
A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers - Full Text View - ClinicalTrials.gov
www.clinicaltrials.gov -
 
PATIENT RESOURCES
Guideline for Hand Hygiene in Health-Care Settings Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force
www.cdc.gov - 10/24/02
Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients
www.cdc.gov - 10/19/00
www.cdc.gov/mmwr/PDF/wk/mm5818.pdf
www.cdc.gov -


 
CONNECT WITH US
 Become a fan on
 Facebook
 Add us on
 Google Plus
 Follow us on
 Twitter
 Join our
 LinkedIn group
 Sign up for our
 Newsletters
 Subscribe to our
 RSS Feed

 

Bacterial Conjunctivitis

  • Infant and Toddler With History of Cough

    A 6-month-old boy has a 1-week history of dry cough that worsens at night. He has been wheezing intermittently for the past month. A 2-year-old girl has had severe nighttime cough, congestion, and fever for 2 days. She recently recovered from a respiratory illness of 1 month's duration. Chest radiographs of both patients are shown… Read More

  • Recommendations for Flu Vaccination

    Last year, the Advisory Committee on Immunization Practices updated its vaccination recommendations to include new guidelines for children ages 6 months through 8 years, and for persons with egg allergy. Read More

  • Exercise and Asthma Guidelines

    Patients with asthma may be reluctant to exercise for fear of triggering an attack. You can reassure them that adequate control can allow them to participate in almost any physical activity they wish. Recommendations from the NIH offer guidance on prevention of exercise-induced bronchospasm… Read More

  • Infant With Persistent Fever and Cough, Worsening Rash

    A  14-month-old girl presented with persistent fever, cough, and worsening rash of 5 days' duration. On the first day of the illness, the infant was brought to an acute care clinic for evaluation. Read More


 
 
LATEST FEATURES
February 1, 2005
Do You Recognize These Eye Disorders?
The parents of this child are concerned that her eyes are “crossed.” Is this condition cause for concern? More »
June 1, 2003
Staphylococcal Scalded Skin Syndrome
More »
Showing 41 - 42 of 42 results.
Page of 9
First Next Last
 
RELATED CONTENT

Do You Recognize These Eye Disorders?
Consultant for Pediatricians,  February 1, 2005
Orbital Abscess
Consultant for Pediatricians,  October 1, 2006
Photoclinic: Corneal Abrasion
Consultant for Pediatricians,  September 1, 2006
 
JOURNAL SCAN
BMC Infectious Diseases | Full text | Non-capsulated and capsulated Haemophilus influenzae in children with acute otitis media in Venezuela: a prospective epidemiological study
www.biomedcentral.com - 2/14/12
Non-typeable Haemophilus influenzae (NTHi) and Streptococcus pneumoniae are major causes of bacterial acute otitis media (AOM). Data regarding AOM are limited in Latin America. This is the first active surveillance in a private setting in Venezuela to characterize the bacterial etiology of AOM in children < 5 years of age.|Non-typeable Haemophilus influenzae (NTHi) and Streptococcus pneumoniae are major causes of bacterial acute otitis media (AOM). Data regarding AOM are limited in Latin America. This is t
Annals of Emergency Medicine - Related By Results
www.annemergmed.com -
In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients. ... Clinical Safety of Moxifloxacin Ophthalmic Solution 0.5 ( VIGAMOX) in
 
MEDLINE
Ocular findings of oral sildenafil use in term and near-term neonates.
pubmed.gov - 4/2/10
Sildenafil is a phosphodiesterase type 5 inhibitor used as a therapeutic adjunct in critically ill neonates with persistent pulmonary hypertension. Sildenafil is associated with several ocular complications in adults and is suspected to exacerbate retinopathy of prematurity (ROP). The risk of ocular complication in sildenafil-treated newborns, not otherwise at risk for the development of ROP, is unknown.|Twenty-two neonates with birth gestational age greater than 34 weeks and birth weight over 2,100 g who received oral sildenafil for more than 2 weeks were assessed by a pediatric ophthalmologist for potential ocular complications.|Four patients had ocular findings: 2 had bacterial conjunctivitis; 1 had optic nerve hypoplasia, choroidal coloboma, and nystagmus; 1 had previously suffered from a hypotensive episode and had a documented cortical injury accompanied by bilateral optic disk atrophy and nystagmus. All cases seemed unrelated to sildenafil use and improved despite continued use
Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
pubmed.gov - 4/1/10
Acute conjunctivitis is the most frequent eye disorder seen by primary care physicians and one that often affects children. Besifloxacin is a new topical fluoroquinolone, the first chlorofluoroquinolone, for the treatment of bacterial conjunctivitis.|To examine the efficacy and safety of besifloxacin ophthalmic suspension 0.6% in patients aged 1-17 years with bacterial conjunctivitis.|This was a post hoc analysis of a subgroup of pediatric patients aged 1-17 years who had participated in three previously reported, randomized, double-masked, parallel-group, multicenter, clinical trials evaluating the safety and efficacy of besifloxacin in the treatment of bacterial conjunctivitis. The studies were conducted in a community setting (clinical centers). All three clinical trials included children (aged > or = 1 year) with a clinical diagnosis of bacterial conjunctivitis in at least one eye, based on the presence at baseline of grade 1 or greater purulent conjunctival discharge and
Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients.
pubmed.gov - 3/1/10
Purulent bacterial conjunctivitis affects all ages with high frequency in newborns and children. In a subset of 150 children included in a large study having enrolled 1043 patients, our aim was to analyze in children, the efficacy and safety of azithromycin 1.5% eye-drops in the treatment of this disease.|This multicenter, randomized, investigator-masked, parallel-group study, included 150 children and adolescents to study safety and compare azithromycin 1.5% eye drops twice daily for 3 days and tobramycin 0.3% 1 drop every 2 hours for 2 days then 4 times daily for 5 days. Out of 150 patients included, 58 had positive cultures and were studied for efficacy. Signs and symptoms were evaluated and cultures obtained at baseline, Days 3 and 9. Primary efficacy variable was the clinical cure (score 0 for bulbar conjunctival injection and purulent discharge) at the test of cure visit (day 9).|Both treatments were effective with a clinical and microbiologic cure of more than 80% of children
Moxifloxacin versus polymyxin B/trimethoprim sulfate in pediatric bacterial conjunctivitis.
pubmed.gov - 12/1/08
19043943 2008 12 02 2008 12 29 2012 11 15 0191-3913 45 6 2008 Nov-Dec J Pediatr Ophthalmol Strabismus 330 Wagner Rudolph S RS eng Comment Comparative Study Editorial United States J Pediatr Ophthalmol Strabismus 7901143 0191-3913 0 Anti-Infective
Clinical features of bacterial conjunctivitis in children.
pubmed.gov - 1/1/07
Conjunctivitis is a common cause of primary care and emergency department (ED) visits. There is a paucity of data in recent literature on the prevalence of pediatric bacterial conjunctivitis, and there are no evidence-based clinical guidelines for empirical treatment. The study objective was to describe clinical features most predictive of bacterial conjunctivitis.|This was a prospective study in a children's hospital ED. Conjunctival swabs for bacterial culture were obtained from patients aged 1 month to 18 years presenting with red or pink eye and/or the diagnosis of conjunctivitis.|A total of 111 patients were enrolled over one year. Patients had a mean (+/-SD) age of 33.2 (+/-37.5) months, and 55% were male. Eighty-seven patients (78%) had positive bacterial cultures. Nontypeable Haemophilus influenzae accounted for 82% (71/87), Streptococcus pneumoniae for 16% (14/87), and Staphylococcus aureus for 2.2% (2/87). Five clinical variables were significantly associated with a positive



 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 
 
MOST POPULAR
 
COMMENTS